RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 86 filers reported holding RELMADA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 2.25 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $0 | -100.0% | 192 | -98.4% | 0.00% | – |
| Q1 2023 | $27 | -37.2% | 12,150 | -1.7% | 0.00% | – |
| Q4 2022 | $43 | -100.0% | 12,359 | -63.2% | 0.00% | -100.0% |
| Q3 2022 | $1,244,000 | +224.8% | 33,596 | +66.5% | 0.00% | – |
| Q2 2022 | $383,000 | +8.8% | 20,181 | +54.7% | 0.00% | – |
| Q1 2022 | $352,000 | +19.7% | 13,044 | 0.0% | 0.00% | – |
| Q4 2021 | $294,000 | -14.0% | 13,044 | -0.1% | 0.00% | – |
| Q3 2021 | $342,000 | -18.0% | 13,053 | +0.3% | 0.00% | – |
| Q2 2021 | $417,000 | -8.1% | 13,014 | +0.9% | 0.00% | -100.0% |
| Q1 2021 | $454,000 | +9.7% | 12,900 | 0.0% | 0.00% | – |
| Q4 2020 | $414,000 | -14.6% | 12,900 | 0.0% | 0.00% | -100.0% |
| Q3 2020 | $485,000 | -15.9% | 12,900 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $577,000 | – | 12,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Guild Investment Management, Inc. | 205,300 | $615,900 | 1.03% |
| Deep Track Capital, LP | 2,837,818 | $8,513,454 | 0.33% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 974,082 | $2,922,246 | 0.23% |
| apricus wealth, LLC | 77,362 | $239,822 | 0.21% |
| Palo Alto Investors LP | 732,400 | $2,197,200 | 0.21% |
| RTW INVESTMENTS, LP | 2,131,835 | $6,395,505 | 0.14% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 100,000 | $300,000 | 0.09% |
| AdvisorShares Investments LLC | 112,908 | $338,724 | 0.09% |
| Savior LLC | 3,500 | $10,500 | 0.07% |
| Spotlight Asset Group, Inc. | 20,000 | $60,000 | 0.05% |